Hyperion DeFi (HYPD)
NASDAQ:HYPD
Top Page
Hyperion DeFi
(NASDAQ:HYPD)
Select Model
Select Model
Rating:54Neutral
Price Target:
$3.50
▼(-9.09% Downside)
Action:ReiteratedDate:03/27/26
Overall score reflects improving capitalization and a positive earnings-call outlook with guidance for growth, but it is held back most by weak underlying financial quality (persistent losses and cash burn) and a technical picture that remains below key longer-term moving averages. Valuation appears low on P/E, but lacks dividend support and may be distorted by volatile earnings.
Positive Factors
Balance sheet improvement
An improved 2025 balance sheet with positive equity signals materially reduced insolvency risk versus 2024. This stronger capitalization provides the company with more runway to execute its digital-asset strategy, access capital on better terms, and withstand token volatility while pursuing revenue conversion.
Negative Factors
Negative cash flow
Persistent negative operating and free cash flow, including sizable 2025 cash burn, is a durable financing constraint. Until revenue growth reliably converts to cash, the company will remain dependent on external funding, limiting strategic flexibility and increasing execution risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet improvement
An improved 2025 balance sheet with positive equity signals materially reduced insolvency risk versus 2024. This stronger capitalization provides the company with more runway to execute its digital-asset strategy, access capital on better terms, and withstand token volatility while pursuing revenue conversion.
Read all positive factors
Hyperion DeFi (HYPD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$41.35M
Dividend YieldN/A
Average Volume (3M)1.09M
Price to Earnings (P/E)―
Beta (1Y)3.05
Revenue Growth984.82%
EPS Growth63.54%
CountryUS
Employees13
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)-6.29
Shares Outstanding11,391,645
10 Day Avg. Volume701,310
30 Day Avg. Volume1,085,571
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.43
Price to Sales (P/S)21.88
P/FCF Ratio-1.21
Enterprise Value/Market Cap0.49
Enterprise Value/Revenue24.82
Enterprise Value/Gross Profit46.45
Enterprise Value/Ebitda-2.23
Forecast
1Y Price Target
$8.25Price Target Upside114.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.98
Revenue Forecast (FY)$6.66M
Hyperion DeFi Business Overview & Revenue Model
Company Description
A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq...
Hyperion DeFi Earnings Call Summary
Earnings Call Date:Nov 13, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:May 07, 2026
Earnings Call Sentiment Positive
The earnings call reflects a positive transformation and growth trajectory for Hyperion DeFi, marked by record financial metrics, successful strategic initiatives, and promising guidance. However, challenges related to regulatory uncertainty and reliance on nonrecurring gains were noted.Positive Updates
Record Income from Operations
Achieved income from operations of $4.4 million and GAAP net income of $6.6 million, both record highs for the company.
Negative Updates
Regulatory Uncertainty
Operating in an extremely dynamic regulatory environment, although broadly favorable, presents challenges regarding clarity around crypto and DeFi interactions with existing financial infrastructure.
Read all updates
Q3-2025 Updates
Positive
Negative
Record Income from Operations
Achieved income from operations of $4.4 million and GAAP net income of $6.6 million, both record highs for the company.
Read all positive updates
Company Guidance
During the call, Hyperion DeFi provided comprehensive guidance and metrics highlighting its strategic transformation and financial performance for the third quarter of 2025. The company reported a record GAAP net income of $6.6 million and an adjusted EBITDA of $8.0 million. Hyperliquid, the blockchain ecosystem Hyperion focuses on, generates approximately $1.3 billion in annualized revenue based on a $3.5 million daily run rate, making it the #1 revenue-generating blockchain excluding stablecoins. The Hyperliquid ecosystem has amassed over 800,000 users and facilitates up to 100,000 transactions per second. Hyperion DeFi holds 1.7 million HYPE tokens, valued at approximately $77.8 million, including liquid staking tokens, contributing to its strategic treasury. The company anticipates Q4 2025 adjusted revenues between $475,000 and $515,000, aiming for operating cash flow positivity in 2026. Hyperion DeFi’s strategy leverages its digital asset treasury for revenue generation through staking, validator commissions, yield enhancement, and DeFi monetization, with a focus on expanding institutional-grade infrastructure.Hyperion DeFi Financial Statement Overview
Summary
Income Statement
14
Very Negative
Balance Sheet
52
Neutral
Cash Flow
18
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 813.46K | 57.34K | 3.79K | 0.00 | 14.00M |
| Gross Profit | 510.17K | -3.87M | -12.22K | 0.00 | 12.40M |
| EBITDA | -18.98M | -46.21M | -24.11M | -26.32M | -12.17M |
| Net Income | -45.31M | -49.82M | -27.26M | -28.01M | -12.78M |
Balance Sheet | |||||
| Total Assets | 51.76M | 3.67M | 28.78M | 31.04M | 31.66M |
| Cash, Cash Equivalents and Short-Term Investments | 6.44M | 2.12M | 14.85M | 22.86M | 19.46M |
| Total Debt | 8.51M | 11.24M | 16.08M | 10.12M | 7.15M |
| Total Liabilities | 10.70M | 16.76M | 19.78M | 13.80M | 11.19M |
| Stockholders Equity | 41.06M | -13.10M | 9.00M | 17.23M | 20.47M |
Cash Flow | |||||
| Free Cash Flow | -14.77M | -30.28M | -27.81M | -25.98M | -22.49M |
| Operating Cash Flow | -14.77M | -30.12M | -23.84M | -25.11M | -20.87M |
| Investing Cash Flow | -71.95M | -161.48K | -3.97M | -874.75K | -1.62M |
| Financing Cash Flow | 91.05M | 17.55M | 19.79M | 21.51M | 21.46M |
Hyperion DeFi Technical Analysis
Negative
3.85
Price Trends
3.47
Negative
3.59
Negative
6.19
Negative
Market Momentum
-0.06
Positive
47.58
Neutral
36.18
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HYPD, the sentiment is Negative. The current price of 3.85 is above the 20-day moving average (MA) of 3.44, above the 50-day MA of 3.47, and below the 200-day MA of 6.19, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 47.58 is Neutral, neither overbought nor oversold. The STOCH value of 36.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HYPD.
Hyperion DeFi Risk Analysis
Hyperion DeFi disclosed 65 risk factors in its most recent earnings report. Hyperion DeFi reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Hyperion DeFi Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
54 Neutral | $41.35M | -0.39 | -129.97% | ― | 984.82% | 63.54% | |
52 Neutral | $73.91M | -5.13 | -15.11% | ― | -13.79% | -132.21% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | $22.21M | -2.58 | -221.04% | ― | -18.96% | 8.98% | |
44 Neutral | $37.93M | -4.85 | -91.54% | ― | -8.97% | 47.29% | |
44 Neutral | $25.39M | -1.43 | -441.55% | ― | 12.24% | 47.45% |
* Healthcare Sector Average
HYPD
Hyperion DeFi
3.63
2.68
282.11%
CTSO
Cytosorbents
0.61
-0.36
-37.24%
SRTS
Sensus Healthcare
4.49
-0.12
-2.60%
TELA
TELA Bio
0.57
-0.41
-42.14%
ICCM
Icecure Medical
0.32
-0.78
-70.64%
BDMD
Baird Medical Investment Holdings
1.77
-3.27
-64.88%
Hyperion DeFi Corporate Events
Business Operations and StrategyFinancial DisclosuresShareholder Meetings
Hyperion DeFi Reports Strong Growth Amid Crypto Volatility
Positive
Mar 26, 2026
On March 20, 2026, Hyperion DeFi’s board approved third amended and restated bylaws that lower the quorum for shareholder meetings to one-third of voting shares from a simple majority and formally allow shareholder action via written consent...
Business Operations and StrategyExecutive/Board Changes
Hyperion DeFi Finalizes Leadership Team and Equity Conversion
Positive
Jan 5, 2026
On January 5, 2026, Hyperion DeFi converted 100,000 shares of its Series A Non-Voting Preferred Stock into 300,000 common shares, for no additional consideration, in an unregistered transaction relying on private offering exemptions, modestly shif...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.